TNF and inflammatory bowel disease: As TNFα plays a pivotal role in the pathophysiology of IBD, confirmed by the efficacy of anti-TNF drugs, such as infliximab and adalimumab (105), Meijer et al. investigated the association between a SNP (G308A) in TNFα and fibrostenotic disease (88).